Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf Mounjaro is not working as you expected, the most useful first step is to establish whether the treatment genuinely isn't effective or whether something fixable is getting in the way. Most people who feel the medicine has stopped working find a clear, addressable reason when they look methodically — dose timing, injection technique, dietary patterns, or simply the fact that 2.5mg is a settling-in dose rather than a full therapeutic one. These are prescription-only medicines, and any decision to change, pause or stop should be made with your prescriber, not unilaterally.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The single most common reason people feel Mounjaro has stopped working is that they're still on a starter dose. The 2.5mg pen exists to let your body adjust to the medicine — its job is tolerability, not weight loss. Therapeutic effect builds as the dose increases, typically in four-week steps under your prescriber's direction. If you are a few weeks into your first pen and the scales haven't moved, that is expected, not a failure.
Beyond dose, run through this checklist in under a minute: Is the pen stored in the fridge between 2°C and 8°C? Is the needle changed for every injection? Is the injection going into the right site (abdomen, thigh or upper arm) with the skin pinched? And has every dose actually been given on schedule? A single missed dose in a four-week cycle can blunt the effect noticeably. If any of these answers is uncertain, that's the place to start. Our frequently asked questions cover technique and storage queries in detail.
It is also worth logging what you've eaten for three days honestly. GLP-1 medicines reduce appetite dramatically for many people, but they don't eliminate the need for a calorie deficit. If appetite suppression has led to eating very little protein (a common pattern) muscle loss can affect body composition in ways the scales don't fully capture. Protein adequacy matters throughout treatment.
If you have moved through the titration ladder and are now at 5mg or above, expectations shift. How long Mounjaro takes to work varies between individuals, but most clinical data show meaningful weight loss becoming visible between weeks eight and sixteen at therapeutic doses. Comparing your week-six progress to trial averages at week seventy-two is not a fair comparison.
The SURMOUNT-1 trial (involving around 2,500 adults with obesity) reported average body-weight reductions of around 20% at the 15mg dose over 72 weeks, as published in the New England Journal of Medicine. That figure represents a long-term trajectory, not a six-week snapshot. Progress is rarely linear: weeks of little movement followed by a noticeable drop are a recognised pattern, not a sign of failure. Weighing yourself at the same time each morning (after using the bathroom, before eating) gives cleaner data than sporadic or evening weigh-ins.
If you're specifically finding that a particular dose has stopped producing results after several consistent weeks, the question to bring to your prescriber is whether a dose increase is appropriate. That conversation is exactly what clinical review is for. For more on dose-specific response, the 5mg Mounjaro page goes into the evidence for that strength in particular.
NICE's appraisal of tirzepatide (TA1026) sets out a clear benchmark: if weight loss is less than 5% after six months at the highest dose the person can tolerate, continuing treatment should be reviewed. That is the formal threshold for what clinicians mean by non-response, not three weeks at 2.5mg, and not a plateau during a stressful month.
If you are approaching or past that threshold, speak to your prescriber. Options at that point include reviewing the dose further, examining lifestyle factors in more depth, or discussing whether a different medicine might be better suited to your physiology. There is no single treatment that works identically for everyone, and a good clinical relationship accommodates that honestly.
For anyone weighing up what to do if Mounjaro is not working as expected, our guide to why Mounjaro may not be working for you covers the more nuanced reasons, including physiological factors, drug interactions and conditions that affect absorption. If you want to explore whether Mounjaro is not working for you specifically, that page looks at individual variation in response in more depth. Context around the broader relationship between Mounjaro and weight loss is also useful if you want to understand the mechanism side more fully.
For context on what treatment costs include, and why clinical oversight matters throughout a course of treatment, the weight-loss treatment overview sets that out plainly. Treatment decisions (including stopping, switching or continuing) should always stay inside a clinical conversation. If you'd like our prescribers to review your situation, you can check your eligibility and start a free consultation at any point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.